Clinical trial
A Phase IV, Open-label, Safety and Tolerability Trial of MK-3641 and MK-7243 Coadministered in Subjects At Least 18 Years of Age With Ragweed and Grass Pollen Induced Allergic Rhinitis With or Without Conjunctivitis
NCT02256553 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IV, Open-label, Safety and Tolerability Trial of MK-3641 and MK-7243 Coadministered in Subjects At Least 18 Years of Age With Ragweed and Grass Pollen Induced Allergic Rhinitis With or Without Conjunctivitis
- Lead sponsor
- ALK-Abelló A/S
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- February 28, 2015
- Enrollment
- 102 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.